Sex differences in kappa opioid pharmacology

Life Sciences

Volumn 88, Issue 1-2, 2011, Pages 2-16

  Rasakham, Khampaseuth ^a   Liu Chen, Lee Yuan ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Analgesia; Antipruritic; Drug abuse; Kappa opioid receptor; Mood disorder; Sex difference

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 4 [(3,4 DICHLOROPHENYL)ACETYL] 3 (1 PYRROLIDINYLMETHYL) 1 PIPERAZINECARBOXYLIC ACID METHYL ESTER; BREMAZOCINE; BRL 52537; BUTORPHANOL; CAPSAICIN; ENANDOLINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALBUPHINE; NALFURAFINE; NALORPHINE; NORBINALTORPHIMINE; PENTAZOCINE; SALVINORIN A; SEX HORMONE; SPIRADOLINE; UNCLASSIFIED DRUG;

ANALGESIA; ANTINOCICEPTION; ARTICLE; CHRONIC PAIN; CONTACT ALLERGY; DIURESIS; DRUG ABUSE; FEEDING; HUMAN; JAW DISEASE; MOOD DISORDER; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PAIN; POSTOPERATIVE PAIN; PROLACTIN RELEASE; RAT STRAIN; SEX CHROMOSOME; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STRAIN DIFFERENCE;

ANIMALIA;

EID: 78650523941     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.10.007     Document Type: Review

References (145)

1. H. Baba, T.P. Doubell, and C.J. Woolf Peripheral inflammation facilitates Abeta fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord J Neurosci 19 2 1999 859 867
2. A.C. Barrett, C.D. Cook, J.M. Terner, E.L. Roach, C. Syvanthong, and M.J. Picker Sex and rat strain determine sensitivity to kappa opioid-induced antinociception Psychopharmacol Berl 160 2 2002 170 181
3. A.C. Barrett, E.S. Smith, and M.J. Picker Sex-related differences in mechanical nociception and antinociception produced by mu- and kappa-opioid receptor agonists in rats Eur J Pharmacol 452 2 2002 163 173
4. R.E. Bartok, and R.M. Craft Sex differences in opioid antinociception J Pharmacol Exp Ther 282 2 1997 769 778
5. J.B. Becker, and M. Hu Sex differences in drug abuse Front Neuroendocrinol 29 1 2008 36 47
6. D.A. Bereiter Sex differences in brainstem neural activation after injury to the TMJ region Cells Tissues Organs 169 3 2001 226 237
7. K.L. Bigos, B.G. Pollock, B.A. Stankevich, and R.R. Bies Sex differences in the pharmacokinetics and pharmacodynamics of antidepressants: an updated review Gend Med 6 4 2009 522 543
8. W. Binder, J. Carmody, and J. Walker Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids J Pharmacol Exp Ther 292 1 2000 303 309
9. R.J. Bodnar, and B. Kest Sex differences in opioid analgesia, hyperalgesia, tolerance and withdrawal: central mechanisms of action and roles of gonadal hormones Horm Behav 58 1 2010 72 81
10. E.R. Butelman, M. Mandau, K. Tidgewell, T.E. Prisinzano, V. Yuferov, and M.J. Kreek Effects of salvinorin A, a kappa-opioid hallucinogen, on a neuroendocrine biomarker assay in nonhuman primates with high kappa-receptor homology to humans J Pharmacol Exp Ther 320 1 2007 300 306
11. W.A. Carlezon Jr., C. Beguin, J.A. Dinieri, M.H. Baumann, M.R. Richards, and M.S. Todtenkopf Depressive-Like Effects of the {kappa}-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats J Pharmacol Exp Ther 316 1 2006 440 447
12. G.V. Carr, D.A. Bangasser, T. Bethea, M. Young, R.J. Valentino, and I. Lucki Antidepressant-like effects of kappa-opioid receptor antagonists in wistar kyoto rats Neuropsychopharmacology 35 3 2010 752 763
13. G.V. Carr, and I. Lucki Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats Psychopharmacol Berl 210 2 2010 295 302
14. T.Y. Chen, T. Goyagi, T.J. Toung, J.R. Kirsch, P.D. Hurn, and R.C. Koehler Prolonged opportunity for ischemic neuroprotection with selective kappa-opioid receptor agonist in rats Stroke 35 5 2004 1180 1185
15. F. Claessens, S. Denayer, N. Van Tilborgh, S. Kerkhofs, C. Helsen, and A. Haelens Diverse roles of androgen receptor (AR) domains in AR-mediated signaling Nucl Recept Signal 6 2008 e008
16. J.T. Clemente, C.A. Parada, M.C. Veiga, R.W. Gear, and C.H. Tambeli Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint Neurosci Lett 372 3 2004 250 255
17. B.M. Cohen, and B. Murphy The effects of pentazocine, a kappa agonist, in patients with mania Int J Neuropsychopharmacol 11 2 2008 243 247
18. C.D. Cook, A.C. Barrett, E.L. Roach, J.R. Bowman, and M.J. Picker Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor Psychopharmacol Berl 150 4 2000 430 442
19. C.J. Cook Steroidal hormones determine sex-related differences in opioid-induced elevation of nociceptive threshold in sheep (Ovis aries) N Z V J 46 2 1998 68 71
20. K.P. Cosgrove, and M.E. Carroll Differential effects of bremazocine on oral phencyclidine (PCP) self-administration in male and female rhesus monkeys Exp Clin Psychopharmacol 12 2 2004 111 117
21. R.M. Craft Sex differences in opioid analgesia: "from mouse to man" Clin J Pain 19 3 2003 175 186
22. R.M. Craft, and S.A. Bernal Sex differences in opioid antinociception: kappa and 'mixed action' agonists Drug Alcohol Depend 63 3 2001 215 228
23. R.M. Craft, P.J. Kruzich, J.S. Boyer, J.W. Harding, and J.M. Hanesworth Sex differences in discriminative stimulus and diuretic effects of the kappa opioid agonist U69, 593 in the rat Pharmacol Biochem Behav 61 4 1998 395 403
24. R.M. Craft, and D.M. McNiel Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats Pharmacol Biochem Behav 75 1 2003 235 245
25. R.M. Craft, J.S. Mogil, and A.M. Aloisi Sex differences in pain and analgesia: the role of gonadal hormones Eur J Pain 8 5 2004 397 411
26. R.M. Craft, C.M. Ulibarri, and D.J. Raub Kappa opioid-induced diuresis in female vs. male rats Pharmacol Biochem Behav 65 1 2000 53 59
27. A. Dahan, B. Kest, A.R. Waxman, and E. Sarton Sex-specific responses to opiates: animal and human studies Anesth Analg 107 1 2008 83 95
28. M.E. Dawson-Basoa, and A.R. Gintzler Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms Pain 64 1 1996 169 177
29. C.T. Drake, A.X. De Oliveira, J.A. Harris, D.M. Connor, C.W. Winkler, and S.A. Aicher Kappa opioid receptors in the rostral ventromedial medulla of male and female rats J Comp Neurol 500 3 2007 465 476
30. D.C. Eikenburg, A.J. Ravitz, G.A. Gudelsky, and K.E. Moore Effects of estrogen on prolactin and tuberoinfundibular dopaminergic neurons J Neural Transm 40 4 1977 235 244
31. J.C. Elliott, M.J. Picker, A.J. Sparrow, and D.T. Lysle Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats Psychopharmacol Berl 185 1 2006 66 75
32. J.C. Elliott, A.F. Wagner, and D.T. Lysle Neurokinin 1 receptor signaling mediates sex differences in mu and kappa opioid-induced enhancement of contact hypersensitivity J Neuroimmunol 181 1-2 2006 100 105
33. R.B. Fillingim, and R.W. Gear Sex differences in opioid analgesia: clinical and experimental findings Eur J Pain 8 5 2004 413 425
34. R.B. Fillingim, B.A. Hastie, T.J. Ness, T.L. Glover, C.M. Campbell, and R. Staud Sex-related psychological predictors of baseline pain perception and analgesic responses to pentazocine Biol Psychol 69 1 2005 97 112
35. R.B. Fillingim, T.J. Ness, T.L. Glover, C.M. Campbell, D.D. Price, and R. Staud Experimental pain models reveal no sex differences in pentazocine analgesia in humans Anesthesiology 100 5 2004 1263 1270
36. P.S. Frankel, M.E. Alburges, L. Bush, G.R. Hanson, and S.J. Kish Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users Neuropharmacology 55 1 2008 41 46
37. R.W. Gear, N.C. Gordon, P.H. Heller, S. Paul, C. Miaskowski, and J.D. Levine Gender difference in analgesic response to the kappa-opioid pentazocine Neurosci Lett 205 3 1996 207 209
38. R.W. Gear, N.C. Gordon, M. Hossaini-Zadeh, J.S. Lee, C. Miaskowski, and S.M. Paul A subanalgesic dose of morphine eliminates nalbuphine anti-analgesia in postoperative pain J Pain 9 4 2008 337 341
39. R.W. Gear, N.C. Gordon, C. Miaskowski, S.M. Paul, P.H. Heller, and J.D. Levine Dose ratio is important in maximizing naloxone enhancement of nalbuphine analgesia in humans Neurosci Lett 351 1 2003 5 8
40. R.W. Gear, N.C. Gordon, C. Miaskowski, S.M. Paul, P.H. Heller, and J.D. Levine Sexual dimorphism in very low dose nalbuphine postoperative analgesia Neurosci Lett 339 1 2003 1 4
41. R.W. Gear, J.S. Lee, C. Miaskowski, N.C. Gordon, S.M. Paul, and J.D. Levine Neuroleptics antagonize nalbuphine antianalgesia J Pain 7 3 2006 187 191
42. R.W. Gear, C. Miaskowski, N.C. Gordon, S.M. Paul, P.H. Heller, and J.D. Levine Action of naloxone on gender-dependent analgesic and antianalgesic effects of nalbuphine in humans J Pain 1 2 2000 122 127
43. R.W. Gear, C. Miaskowski, N.C. Gordon, S.M. Paul, P.H. Heller, and J.D. Levine Kappa-opioids produce significantly greater analgesia in women than in men Nat Med 2 11 1996 1248 1250
44. R.W. Gear, C. Miaskowski, N.C. Gordon, S.M. Paul, P.H. Heller, and J.D. Levine The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain Pain 83 2 1999 339 345
45. A.R. Gintzler, and M.C. Bohan Pain thresholds are elevated during pseudopregnancy Brain Res 507 2 1990 312 316
46. L. Gioiosa, X. Chen, R. Watkins, E.A. Umeda, and A.P. Arnold Sex chromosome complement affects nociception and analgesia in newborn mice J Pain 9 10 2008 962 969
47. M.J. Glass, C.J. Billington, and A.S. Levine Opioids and food intake: distributed functional neural pathways? Neuropeptides 33 5 1999 360 368
48. J.D. Greenspan, R.M. Craft, L. LeResche, L. Arendt-Nielsen, K.J. Berkley, and R.B. Fillingim Studying sex and gender differences in pain and analgesia: a consensus report Pain 132 Suppl 1 2007 S26 S45
49. C.J. Gruber, W. Tschugguel, C. Schneeberger, and J.C. Huber Production and actions of estrogens N Engl J Med 346 5 2002 340 352
50. H.B. Gutstein, and H. Akil J.G. Hardman, L.E. Limbird, A.G. Gilman, Opioid Analgesics (Chapter 23) 2001 Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill Co., Inc 569 619
51. J.A. Harris, P.C. Chang, and C.T. Drake Kappa opioid receptors in rat spinal cord: sex-linked distribution differences Neuroscience 124 4 2004 879 890
52. S.M. Hawkins, and M.M. Matzuk The menstrual cycle: basic biology Ann N Y Acad Sci 1135 2008 10 18
53. J.R. Holtman Jr., and E.P. Wala Characterization of the antinociceptive effect of oxycodone in male and female rats Pharmacol Biochem Behav 83 1 2006 100 108
54. C.H. Hubscher, D.L. Brooks, and J.R. Johnson A quantitative method for assessing stages of the rat estrous cycle Biotech Histochem 80 2 2005 79 87
55. Y.L. Hurd, and M. Herkenham Molecular alterations in the neostriatum of human cocaine addicts Synapse 13 4 1993 357 369
56. S. Inan, and A. Cowan Kappa opioid agonists suppress chloroquine-induced scratching in mice Eur J Pharmacol 502 3 2004 233 237
57. P.A. Jarosz The effect of kappa opioid receptor antagonism on energy expenditure in the obese Zucker rat Biol Res Nurs 8 4 2007 294 299
58. P.A. Jarosz, and B.L. Metzger The effect of opioid antagonism on food intake behavior and body weight in a biobehavioral model of obese binge eating Biol Res Nurs 3 4 2002 198 209
59. R.B. Kanarek, B.A. Homoleski, and C. Wiatr Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats Pharmacol Biochem Behav 65 1 2000 97 104
60. M. Kavaliers, and E. Choleris Sex differences in N-methyl-D-aspartate involvement in kappa opioid and non-opioid predator-induced analgesia in mice Brain Res 768 1-2 1997 30 36
61. M. Kavaliers, and D.G. Innes Sex and day-night differences in opiate-induced responses of insular wild deer mice, Peromyscus maniculatus triangularis Pharmacol Biochem Behav 27 3 1987 477 482 (Pubitemid 17107017)
62. S. Kerkhofs, S. Denayer, A. Haelens, and F. Claessens Androgen receptor knockout and knock-in mouse models J Mol Endocrinol 42 1 2009 11 17
63. S.G. Khasar, R.W. Gear, and J.D. Levine Absence of nalbuphine anti-analgesia in the rat Neurosci Lett 345 3 2003 165 168
64. A.T. Knoll, E.G. Meloni, J.B. Thomas, F.I. Carroll, and W.A. Carlezon Jr. Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats J Pharmacol Exp Ther 323 3 2007 838 845
65. M.J. Kreek, J. Schluger, L. Borg, M. Gunduz, and A. Ho Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions J Pharmacol Exp Ther 288 1 1999 260 269
66. M.C. Kren, V.L. Haller, and S.P. Welch The role of gonadal hormones on opioid receptor protein density in arthritic rats. Eur J Pharmacol 578 2-3 2008 177 184
67. H. Kumagai, T. Ebata, K. Takamori, T. Muramatsu, H. Nakamoto, and H. Suzuki Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a Phase III, randomized, double-blind, placebo-controlled study Nephrol Dial Transplant 25 4 2010 1251 1257
68. T.M. Laughlin, T.W. Vanderah, J. Lashbrook, M.L. Nichols, M. Ossipov, and F. Porreca Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors Pain 72 1-2 1997 253 260
69. G.E. Leighton, R.G. Hill, and J. Hughes Intrathecal injection of a kappa opioid agonist produces hyperalgesia in the guinea pig Eur J Pharmacol 157 2-3 1988 241 242
70. G.E. Leighton, R.G. Hill, and J. Hughes The effects of the kappa agonist PD-117302 on feeding behaviour in obese and lean Zucker rats Pharmacol Biochem Behav 31 2 1988 425 429
71. L. LeResche, L. Mancl, J.J. Sherman, B. Gandara, and S.F. Dworkin Changes in temporomandibular pain and other symptoms across the menstrual cycle Pain 106 3 2003 253 261
72. X. Li, and N. Rahman Impact of androgen/estrogen ratio: lessons learned from the aromatase over-expression mice Gen Comp Endocrinol 159 1 2008 1 9
73. K.G. Lilley, R.J. Epping, and L.M. Hafner The guinea pig estrous cycle: correlation of vaginal impedance measurements with vaginal cytologic findings Lab Anim Sci 47 6 1997 632 637
74. N.J. Liu, H. von Gizycki, and A.R. Gintzler Sexually dimorphic recruitment of spinal opioid analgesic pathways by the spinal application of morphine J Pharmacol Exp Ther 322 2 2007 654 660
75. L.-Y. Liu-Chen Agonist-induced regulation and trafficking of kappa opioid receptors Life Sci 75 5 2004 511 536
76. L.M. Lomas, A.C. Barrett, J.M. Terner, D.T. Lysle, and M.J. Picker Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats Psychopharmacol Berl 191 2 2007 273 285
77. D.R. Loyd, and A.Z. Murphy Sex differences in the anatomical and functional organization of the periaqueductal gray-rostral ventromedial medullary pathway in the rat: a potential circuit mediating the sexually dimorphic actions of morphine J Comp Neurol 496 5 2006 723 738
78. M.C. Luo, Q. Chen, M.H. Ossipov, D.R. Rankin, F. Porreca, and J. Lai Spinal dynorphin and bradykinin receptors maintain inflammatory hyperalgesia 5922 J Pain 9 12 2008 1096 1105
79. J.L. Lynch, J.F. Alley, L. Wellman, and A.J. Beitz Decreased spinal cord opioid receptor mRNA expression and antinociception in a Theiler's murine encephalomyelitis virus model of multiple sclerosis Brain Res 1191 2008 180 191
80. K.B. Mackay, K. Kusumoto, D.I. Graham, and J. McCulloch Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat Brain Res 629 1 1993 10 18
81. S.D. Mague, A.M. Pliakas, M.S. Todtenkopf, H.C. Tomasiewicz, Y. Zhang, and W.C. Stevens Jr. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats J Pharmacol Exp Ther 305 1 2003 323 330
82. A. Mansour, H. Khachaturian, M.E. Lewis, H. Akil, and S.J. Watson Anatomy of CNS opioid receptors Trends Neurosci 11 1988 308 314
83. J. Manzanares, E.J. Wagner, K.E. Moore, and K.J. Lookingland Kappa opioid receptor-mediated regulation of prolactin and alpha-melanocyte-stimulating hormone secretion in male and female rats Life Sci 53 10 1993 795 801
84. M. Martin, A. Matifas, R. Maldonado, and B.L. Kieffer Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones Eur J Neurosci 17 4 2003 701 708
85. D.C. Mash, and J.K. Staley D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims Ann NY Acad Sci 877 1999 507 522
86. C.R. McLaughlin, Q. Tao, and M.E. Abood Analysis of the antinociceptive actions of the kappa-opioid agonist enadoline (CI-977) in neonatal and adult rats: comparison to kappa-opioid receptor mRNA ontogeny Drug Alcohol Depend 38 3 1995 261 269
87. J.P. McLaughlin, B.B. Land, S. Li, J.E. Pintar, and C. Chavkin Prior activation of kappa opioid receptors by U50, 488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning Neuropsychopharmacology 31 4 2006 787 794
88. J.P. McLaughlin, M. Marton-Popovici, and C. Chavkin Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses J Neurosci 23 13 2003 5674 5683
89. M.D. Metcalf, and A. Coop Kappa opioid antagonists: past successes and future prospects AAPS J 7 3 2005 E704 E722
90. M.J. Millan Kappa-opioid receptor-mediated antinociception in the rat. I. Comparative actions of mu- and kappa-opioids against noxious thermal, pressure and electrical stimuli J Pharmacol Exp Ther 251 1 1989 334 341
91. P.L. Miller, and A.A. Ernst Sex differences in analgesia: a randomized trial of mu versus kappa opioid agonists South Med J 97 1 2004 35 41
92. J.S. Mogil, S.G. Wilson, E.J. Chesler, A.L. Rankin, K.V. Nemmani, and W.R. Lariviere The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans Proc Natl Acad Sci USA 100 8 2003 4867 4872
93. K. Nakao, and H. Mochizuki Nalfurafine hydrochloride: a new drug for the treatment of uremic pruritus in hemodialysis patients Drugs Today Barc 45 5 2009 323 329
94. S.S. Negus, and N.K. Mello Opioid antinociception in ovariectomized monkeys: comparison with antinociception in males and effects of estradiol replacement J Pharmacol Exp Ther 290 3 1999 1132 1140
95. S.S. Negus, and N.K. Mello Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys Psychopharmacol Berlin 159 3 2002 275 283
96. S.S. Negus, N.K. Mello, P.S. Portoghese, and C.E. Lin Effects of kappa opioids on cocaine self-administration by rhesus monkeys J Pharmacol Exp Ther 282 1 1997 44 55
97. S.S. Negus, D.S. Zuzga, and N.K. Mello Sex differences in opioid antinociception in rhesus monkeys: antagonism of fentanyl and U50, 488 by quadazocine J Pain 3 3 2002 218 226
98. C.K. Ong, and R.A. Seymour Pathogenesis of postoperative oral surgical pain 5920 Anesth Prog 50 1 2003 5 17
99. M.H. Ossipov, J. Lai, T. King, T.W. Vanderah, T.P. Malan Jr., and V.J. Hruby Antinociceptive and nociceptive actions of opioids J Neurobiol 61 1 2004 126 148
100. C.G. Parsons, and P.M. Headley Spinal antinociceptive actions of μ- and kappa-opioids: The importance of stimulus intensity in determining 'selectivity' between reflexes to different modalities of noxious stimulus Br J Pharmacol 98 1989 523 532
101. A. Pfeiffer, V. Brantl, A. Herz, and H.M. Emrich Psychotomimesis mediated by kappa opiate receptors Science 233 1986 774 776
102. E.R. Prossnitz, J.B. Arterburn, and L.A. Sklar GPR30: a G protein-coupled receptor for estrogen Mol Cell Endocrinol 265-266 2007 138 142
103. A. Puig-Ramos, G.S. Santiago, and A.C. Segarra U-69593, a kappa opioid receptor agonist, decreases cocaine-induced behavioral sensitization in female rats Behav Neurosci 122 1 2008 151 160
104. C.T. Qi, H. Zou, C.H. Zhang, Q.L. Xie, M.L. Jin, and L. Yu Effect of GNTI, a kappa opioid receptor antagonist, on MK-801-induced hyperlocomotion and stereotypy in mice Acta Pharmacol Sin 27 11 2006 1401 1408
105. R. Quirion, and C. Pilapil Distribution of multiple opioid receptors in the human brain (Chapter 5) F.A.O. Mendelsohn, G. Paxinos, Receptors in the human nervous system 1991 Academic Press, Inc. San Diego, CA 103 121
106. R. Quirion, C. Pilapil, and J. Magnan Localization of kappa opioid receptor binding sites in human forebrain using [3 H]U69, 593: comparison with [3 H]bremazocine Cell Mol Neurobiol 7 3 1987 303 307
107. W. Rahman, M.R. Dashwood, M. Fitzgerald, A. Aynsley-Green, and A.H. Dickenson Postnatal development of multiple opioid receptors in the spinal cord and development of spinal morphine analgesia Brain Res Dev Brain Res 108 1-2 1998 239 254
108. J.S. Richards, and S.A. Pangas The ovary: basic biology and clinical implications J Clin Invest 120 4 2010 963 972
109. H.W. Sander, P.S. Portoghese, and A.R. Gintzler Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a kappa-selective antagonist Brain Res 474 2 1988 343 347
110. S. Schenk, B. Partridge, and T.S. Shippenberg U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking Psychopharmacol Berl 144 4 1999 339 346
111. R.J. Schepers, J.L. Mahoney, B.J. Gehrke, and T.S. Shippenberg Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation Pain 138 2 2008 423 439
112. M.D. Schmidt, M.S. Schmidt, E.R. Butelman, W.W. Harding, K. Tidgewell, and D.J. Murry Pharmacokinetics of the plant-derived kappa-opioid hallucinogen salvinorin A in nonhuman primates Synapse 58 3 2005 208 210
113. H. Sershen, A. Hashim, and A. Lajtha Gender differences in kappa-opioid modulation of cocaine-induced behavior and NMDA-evoked dopamine release Brain Res 801 1-2 1998 67 71
114. T.S. Shippenberg, V.I. Chefer, A. Zapata, and C.A. Heidbreder Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems Ann NY Acad Sci 937 2001 50 73
115. T.S. Shippenberg, A. LeFevour, and C. Heidbreder kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine J Pharmacol Exp Ther 276 2 1996 545 554
116. T.S. Shippenberg, A. Zapata, and V.I. Chefer Dynorphin and the pathophysiology of drug addiction Pharmacol Ther 116 2 2007 306 321
117. M.A. Smith, P.A. Bryant, and J.M. McClean Social and environmental enrichment enhances sensitivity to the effects of kappa opioids: studies on antinociception, diuresis and conditioned place preference Pharmacol Biochem Behav 76 1 2003 93 101
118. M.A. Smith, K.T. Cole, S.R. Gergans, J.C. Iordanou, M.A. Lyle, and K.T. Schmidt Effects of environmental enrichment on sensitivity to mu, kappa, and mixed-action opioids in female rats Physiol Behav 94 4 2008 563 568
119. Y.R. Smith, C.S. Stohler, T.E. Nichols, J.A. Bueller, R.A. Koeppe, and J.K. Zubieta Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women J Neurosci 26 21 2006 5777 5785
120. R. Spangler, E.M. Unterwald, and M.J. Kreek 'Binge' cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen Brain Res Mol Brain Res 19 4 1993 323 327
121. W.F. Sternberg, E.J. Chesler, S.G. Wilson, and J.S. Mogil Acute progesterone can recruit sex-specific neurochemical mechanisms mediating swim stress-induced and kappa-opioid analgesia in mice Horm Behav 46 4 2004 467 473
122. W.F. Sternberg, J. Ritchie, and J.S. Mogil Qualitative sex differences in kappa-opioid analgesia in mice are dependent on age Neurosci Lett 363 2 2004 178 181
123. E.C. Stoffel, C.M. Ulibarri, J.E. Folk, K.C. Rice, and R.M. Craft Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats J Pain 6 4 2005 261 274
124. J.M. Terner, A.C. Barrett, C.D. Cook, and M.J. Picker Sex differences in (-)-pentazocine antinociception: comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay Behav Pharmacol 14 1 2003 77 85
125. J.M. Terner, A.C. Barrett, E. Grossell, and M.J. Picker Influence of gonadectomy on the antinociceptive effects of opioids in male and female rats Psychopharmacol Berl 163 2 2002 183 193
126. J.M. Terner, L.M. Lomas, E.S. Smith, A.C. Barrett, and M.J. Picker Pharmacogenetic analysis of sex differences in opioid antinociception in rats Pain 106 3 2003 381 391
127. S.A. Tershner, J.M. Mitchell, and H.L. Fields Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function Pain 85 1-2 2000 153 159
128. P.J. Tiseo, M.W. Adler, and L.Y. Liu-Chen Differential release of substance P and somatostatin in the rat spinal cord in response to noxious cold and heat; effect of dynorphin A(1-17) J Pharmacol Exp Ther 252 2 1990 539 545
129. Y. Togashi, H. Umeuchi, K. Okano, N. Ando, Y. Yoshizawa, and T. Honda Antipruritic activity of the kappa-opioid receptor agonist, TRK-820 Eur J Pharmacol 435 2-3 2002 259 264
130. L. Toll, I.P. Berzetei-Gurske, W.E. Polgar, S.R. Brandt, I.D. Adapa, and L. Rodriguez Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications NIDA Res Monogr 178 1998 440 466
131. H. Umeuchi, Y. Kawashima, C.A. Aoki, T. Kurokawa, K. Nakao, and M. Itoh Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride. Eur J Pharmacol 518 2-3 2005 133 139
132. E.M. Unterwald, J.M. Rubenfeld, and M.J. Kreek Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors NeuroReport 5 1994 1613 1616
133. N. Upton, R.D. Sewell, and P.S. Spencer Differentiation of potent mu and kappa-opiate agonists using heat and pressure antinociceptive profiles and combined potency analysis Eur J Pharmacol 78 4 1982 421 429
134. F. van Haaren, S. Scott, and L.B. Tucker kappa-opioid receptor-mediated analgesia: hotplate temperature and sex differences. Eur J Pharmacol 408 2 2000 153 159
135. V. Vecchietti, G.D. Clarke, R. Colle, G. Giardina, G. Petrone, and M. Sbacchi (1 S)-1-(aminomethyl)-2-(arylacetyl)-1, 2, 3, 4-tetrahydroisoquinol ine and heterocycle-condensed tetrahydropyridine derivatives: Members of a novel class of very potent kappa opioid analgesics J Med Chem 34 1991 2624 2633
136. J.D. Veldhuis, A. Iranmanesh, and D.M. Keenan An ensemble perspective of aging-related hypoandrogenemia in men S.J. Winters, N. Totowa, Male Hypogonadism: Basic, Clinical, and Theoretical Principles, Humana 2004 261 284
137. Y. Wang, K. Tang, S. Inan, D. Siebert, U. Holzgrabe, and D.Y. Lee Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo J Pharmacol Exp Ther 312 1 2005 220 230
138. B. Wikstrom, R. Gellert, S.D. Ladefoged, Y. Danda, M. Akai, and K. Ide Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies J Am Soc Nephrol 16 12 2005 3742 3747
139. S.G. Wilson, S.B. Smith, E.J. Chesler, K.A. Melton, J.J. Haas, and B. Mitton The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics J Pharmacol Exp Ther 304 2 2003 547 559
140. M. Xu, M. Petraschka, J.P. McLaughlin, R.E. Westenbroek, M.G. Caron, and R.J. Lefkowitz Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance J Neurosci 24 19 2004 4576 4584
141. J.P. Zacny, and N.J. Beckman The effects of a cold-water stimulus on butorphanol effects in males and females Pharmacol Biochem Behav 78 4 2004 653 659
142. E. Zeynalov, M. Nemoto, P.D. Hurn, R.C. Koehler, and A. Bhardwaj Neuroprotective effect of selective kappa opioid receptor agonist is gender specific and linked to reduced neuronal nitric oxide J Cereb Blood Flow Metab 26 3 2006 414 420
143. Y. Zhang, E.R. Butelman, S.D. Schlussman, A. Ho, and M.J. Kreek Effects of the plant-derived hallucinogen salvinorin A on basal dopamine levels in the caudate putamen and in a conditioned place aversion assay in mice: agonist actions at kappa opioid receptors Psychopharmacol Berlin 179 3 2005 551 558
144. Z. Zhang, T.Y. Chen, J.R. Kirsch, T.J. Toung, R.J. Traystman, and R.C. Koehler Kappa-opioid receptor selectivity for ischemic neuroprotection with BRL 52537 in rats Anesth Analg 97 6 2003 1776 1783
145. J. Zhu, L.-Y. Luo, C. Chen, and L.-Y. Liu-Chen Activation of the cloned human κ opioid receptor by agonists enhances [35 S]GTPγS binding to membranes: Determination of potencies and efficacies of ligands J Pharmacol Exp Ther 282 1997 676 684